| |
Title |
External Id |
| |
Agency |
Next Deadline |
Details |
|
Nutrition Obesity Research Centers (NORCs) (P30) |
RFA-DK-21-015 |
| |
National Institutes of Health (NIH) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jul 30, 2021 Has Passed
|
Title
Nutrition Obesity Research Centers (NORCs) (P30)
Agencies
National Institutes of Health (NIH)
Description
This Funding Opportunity Announcement (FOA) invites applications from institutions/organizations that propose to establish core centers that are part of an integrated and existing program of nutrition and/or obesity research. The Nutrition Obesity Research Centers (NORC) program is designed to support and enhance the national research effort in nutrition and obesity. NORCs support three primary research-related activities: Research Core services, a Pilot and Feasibility (P and F) program, and an Enrichment program. All activities pursued by Nutrition Obesity Research Centers are designed to enhance the efficiency, productivity, effectiveness and multidisciplinary nature of research in nutrition and obesity.
More Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-015.html
Submission Limits
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.
Deadlines
| Internal Notice of Intent |
Jul 30, 2021 |
| Notification of Internal Competition |
Jul 31, 2021 |
| Internal Pre-proposal |
Aug 13, 2021 |
| Results of Internal Competition |
Aug 27, 2021 |
| Agency Notice of Intent/Pre-proposal |
Sep 20, 2021 |
| Agency Proposal |
Oct 20, 2021
|
|
|
CHRB Grants Program - FY 2022-2023 |
CHRB |
| |
Commonwealth Health Research Board (CHRB) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Please note that the "Agency Application Deadline" listed on this page reflects the CHRB's deadline for submittal of concept papers. Full proposal submissions (invited only) will be due April 29, 2021. Also, the guidelines for this submission will be available October 1, 2020. The URL is last year's guidelines.
|
| |
Notice of Intent Deadline of Jul 30, 2021 Has Passed
|
Title
CHRB Grants Program - FY 2022-2023
Agencies
Commonwealth Health Research Board (CHRB)
Description
The Commonwealth Health Research Board [CHRB or Board] was created by Virginia Code §32.1-162.23 to provide financial support—in the form of grants, donations, or other assistance— for research efforts having the potential of maximizing human health benefits for the citizens of the Commonwealth. Research efforts eligible for support by the Board shall include traditional medical and biomedical research relating to the causes and cures of diseases, as well as research related to health services and the delivery of health care. Since its inception, the CHRB has made 230 grant awards totaling approximately $19.2 million in grant
funding to institutions of higher education and other Virginia not-for-profit or nonprofit organizations that conduct health, or
health-related research in Virginia. For a description of past CHRB grant awards and abstracts, visit our website at www.chrb.org.
More Information
https://www.chrb.org/2021-preaward/CHRB-Grant-Guidelines-and-Application-Instructions.pdf
Submission Limits
12 per institution.
The CHRB accepts no more than 12 Concept
Papers from a single agency, non- profit
organization, or institution of higher
education per funding cycle. It is the
responsibility of the Applicant Institution or
Organization to decide which of the 12 or
fewer Concept Papers are submitted.
A Principal Investigator applying for funding
may submit no more than one Concept Paper
per funding cycle.
Deadlines
| Internal Notice of Intent |
Jul 30, 2021 |
| Notification of Internal Competition |
Jul 31, 2021 |
| Internal Pre-proposal |
Aug 13, 2021 |
| Results of Internal Competition |
Aug 23, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Sep 9, 2021
|
|
|
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
RFA-RM-21-025 |
| |
National Institutes of Health (NIH) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jul 30, 2021 Has Passed
|
Title
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
Agencies
National Institutes of Health (NIH)
Description
The purpose of the FIRST Cohort is to transform culture at NIH-funded extramural institutions by building a self-reinforcing community of scientists committed to diversity and inclusive excellence (defined below). Implementing and sustaining cultures of inclusive excellence within the program has the potential to be transformational for biomedical research at the awardee institutions and beyond. This community will be built through recruitment of faculty who are competitive for an advertised research tenure-track or equivalent faculty position (positions must be at the Assistant Professor (or equivalent) level), have not held a position at this level, and have demonstrated strong commitment to promoting diversity and inclusive excellence.
More Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-025.html
Submission Limits
Only one application per institution, normally identified by having a unique DUNS number or NIH IPF number, is allowed. This funding opportunity will accept applications from eligible Highly Resourced Institutions (HRI), Limited-Resourced Institutions (LRI), or Partnerships (any composition of HRI and/or LRI) to develop faculty cohort models. All eligible institutions are categorized into these two types to encourage inclusion and broaden participation. If an institution is applying as an LRI, the institution must include a statement demonstrating that it meets the LRI criteria. See Institutional Support section.
Deadlines
| Internal Notice of Intent |
Jul 30, 2021 |
| Notification of Internal Competition |
Jul 31, 2021 |
| Internal Pre-proposal |
Aug 9, 2021 |
| Results of Internal Competition |
Aug 20, 2021 |
| Agency Notice of Intent/Pre-proposal |
Aug 24, 2021 |
| Agency Proposal |
Sep 24, 2021
|
|
|
Medical Research Program |
N/A |
| |
W. M. Keck Foundation |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
The university is strongly urged to contact Foundation staff during the pre-application counseling period, which takes place between January 1 and February 15 leading up to a May 1 Phase I submission. In addition to the title of your proposed submission, please submit a one page concept paper summarizing the proposed project, methodologies, and key personnel. Also give a brief justification of the need for Keck support and an estimated budget with your notice of intent. A template for this one page paper can be downloaded from this site.
|
| |
Notice of Intent Deadline of Jul 30, 2021 Has Passed — [All slots are filled]
|
Title
Medical Research Program
Agencies
W. M. Keck Foundation
Description
The Foundation strives to fund endeavors that are distinctive and novel in their approach. It encourages projects that are high-risk with the potential for transformative impact. "High-risk" comprises a number of factors, including questions that push the edge of the field, present unconventional approaches to intractable problems, or challenge the prevailing paradigm. In all our programs, "transformative" may mean creation of a new field of research, development of new instrumentation enabling observations not previously possible, or discovery of knowledge that challenges prevailing perspectives. In addition to the above, in the Southern California Program, transformative may also mean positioning an organization for growth and adaptability. Applicants may find it helpful to look over the abstracts of recent grants for understanding funding priorities. Grant abstracts may be found on our website within the particular program of interest.
Funding is awarded to universities and institutions nationwide for projects in research that:
1. Focus on important and emerging areas of research
2. Have the potential to develop breakthrough technologies, instrumentation or methodologies
3. Are innovative, distinctive and interdisciplinary
4. Demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm
5. Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem
6. Does not focus on clinical or translational research, treatment trials or research for the sole purpose of drug development
7. Fall outside the mission of public funding agencies
8. Demonstrate that private philanthropy generally, and the W. M. Keck Foundation in particular, is essential to the project’s success
More Information
http://www.wmkeck.org/
Submission Limits
One per deadline
Deadlines
| Internal Notice of Intent |
Jul 30, 2021 |
| Notification of Internal Competition |
Jul 31, 2021 |
| Internal Pre-proposal |
Aug 6, 2021 |
| Results of Internal Competition |
Aug 16, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Nov 1, 2021
|
|
|
Science and Engineering Program |
N/A |
| |
W. M. Keck Foundation |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
The university is strongly urged to contact Foundation staff during the pre-application counseling period, which takes place between January 1 and February 15 leading up to a May 1 Phase I submission. In addition to the title of your proposed submission, please submit a one page concept paper summarizing the aims, significance, methods, and goals/outcomes of your project with your notice of intent.
|
| |
Notice of Intent Deadline of Jul 30, 2021 Has Passed — [All slots are filled]
|
Title
Science and Engineering Program
Agencies
W. M. Keck Foundation
Description
The Foundation strives to fund endeavors that are distinctive and novel in their approach. It encourages projects that are high-risk with the potential for transformative impact. "High-risk" comprises a number of factors, including questions that push the edge of the field, present unconventional approaches to intractable problems, or challenge the prevailing paradigm. In all our programs, "transformative" may mean creation of a new field of research, development of new instrumentation enabling observations not previously possible, or discovery of knowledge that challenges prevailing perspectives. In addition to the above, in the Southern California Program, transformative may also mean positioning an organization for growth and adaptability. Applicants may find it helpful to look over the abstracts of recent grants for understanding funding priorities. Grant abstracts may be found on our website within the particular program of interest.
Funding is awarded to universities and institutions nationwide for projects in research that:
1. Focus on important and emerging areas of research;
2. Have the potential to develop breakthrough technologies, instrumentation or methodologies;
3. Are innovative, distinctive and interdisciplinary;
4. Demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm;
5. Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem;
6. Does not focus on clinical or translational research, treatment trials or research for the sole purpose of drug development;
7.; Fall outside the mission of public funding agencies
8. Demonstrate that private philanthropy generally, and the W. M. Keck Foundation in particular, is essential to the project’s success
More Information
http://www.wmkeck.org/
Submission Limits
One per institution
Deadlines
| Internal Notice of Intent |
Jul 30, 2021 |
| Notification of Internal Competition |
Jul 31, 2021 |
| Internal Pre-proposal |
Aug 6, 2021 |
| Results of Internal Competition |
Aug 16, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Nov 1, 2021
|
|
|
GERMINATION: Germination of Research Questions for Addressing Critical Societal Challenges |
NSF 21-594 |
| |
National Science Foundation (NSF) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jul 26, 2021 Has Passed — [All slots are filled]
|
Title
GERMINATION: Germination of Research Questions for Addressing Critical Societal Challenges
Agencies
National Science Foundation (NSF)
Description
Engineers and scientists are capable of making enormous impact when they conceive and conduct fundamental research that addresses societal needs. Our world faces many critical challenges engendered in part by the expanding and aging world population, including meeting global needs for food, energy, water, land, and other resources, while respecting and maintaining the balance of our planetary ecosystem. Other notable challenges include addressing climate change; maintaining cybersecurity, privacy, and fairness in our increasingly connected world; and providing, maintaining and protecting infrastructure. All of these represent potentially large and fertile opportunities for science, technology, engineering and mathematics (STEM) research to serve society.
The NSF Directorate for Engineering GERMINATION program aims to foster the development of pedagogical frameworks, platforms and/or environments to enable participants to formulate research questions and ideas with potentially transformative outcomes. The extraordinary response of the STEM research community to the COVID-19 pandemic, exemplified by the record-breaking speed of novel vaccine development, highlights the outstanding capabilities at all levels of the research enterprise. The GERMINATION program seeks to harness the immense capacities of academic researchers to similarly address other critical global challenges through supporting the development of new pedagogical approaches that train researchers to formulate and develop key research questions.
The GERMINATION program invites proposals to design, test, evaluate and implement pedagogical frameworks, platforms and/or environments that enable participants to formulate research questions and ideas that have the potential to address critical societal challenges. In order to catalyze development of novel approaches, while simultaneously expanding the reach of pilot approaches which are already exhibiting promise, two tracks will be supported in Fiscal Year (FY) 2022: GERMINATION Innovation and GERMINATION Expansion. GERMINATION Innovation awards will fund projects to design, test and evaluate previously unexplored pedagogical frameworks, platforms and/or environments that have the explicit goal of enabling the participants to formulate research questions with potentially transformative outcomes. Projects submitted to the Innovation track must use the EArly-concept Grants for Exploratory Research (EAGER) proposal type (see PAPPG Chapter II). GERMINATION Expansion awards will fund projects that focus on development, implementation and scaling of evidence-based strategies for achieving GERMINATION goals. Projects supported under the Expansion track should focus on scaling previously piloted approaches with demonstrated efficacy to a regional or national sphere of activity, and will likely involve development of new collaborative relationships to establish networks capable of implementation beyond the pilot institution.
More Information
https://www.nsf.gov/pubs/2021/nsf21594/nsf21594.htm
Submission Limits
Only 1 proposal may be submitted by a single organization.
Deadlines
| Internal Notice of Intent |
Jul 26, 2021 |
| Notification of Internal Competition |
Jul 27, 2021 |
| Internal Pre-proposal |
Aug 6, 2021 |
| Results of Internal Competition |
Aug 16, 2021 |
| Agency Notice of Intent/Pre-proposal |
Aug 27, 2021 |
| Agency Proposal |
Oct 29, 2021
|
|
|
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed) |
PAR-21-227 |
| |
National Institutes of Health (NIH) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jul 16, 2021 Has Passed
|
Title
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
Agencies
National Institutes of Health (NIH)
Description
This funding opportunity announcement encourages applications for a Resource Center as part of the Support for Research Excellence (SuRE) program to develop and sustain research excellence at U.S. higher education institutions that receive limited NIH research support and serve students from groups underrepresented in biomedical research (see NOT-OD-20-031). The Resource Center will: (1) assist SuRE-eligible institutions to build research capacity, (2) conduct outreach and training to their professional staff and faculty, and (3) collect and report data relevant to the goals of the R16 SuRE programs.
More Information
https://grants.nih.gov/grants/guide/pa-files/PAR-21-227.html
Submission Limits
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.
Deadlines
| Internal Notice of Intent |
Jul 16, 2021 |
| Notification of Internal Competition |
Jul 17, 2021 |
| Internal Pre-proposal |
Jul 30, 2021 |
| Results of Internal Competition |
Aug 16, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Sep 24, 2021
|
|
|
NIH Director's Early Independence Awards (DP5) |
RFA-RM-21-018 |
| |
National Institutes of Health (NIH) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jul 2, 2021 Has Passed
|
Title
NIH Director's Early Independence Awards (DP5)
Agencies
National Institutes of Health (NIH)
Description
The NIH Director's Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
More Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-018.html
Submission Limits
Only up to two applications per institution are allowed as defined in Section III. 3. Additional Information on Eligibility.
Deadlines
| Internal Notice of Intent |
Jul 2, 2021 |
| Notification of Internal Competition |
Jul 3, 2021 |
| Internal Pre-proposal |
Jul 12, 2021 |
| Results of Internal Competition |
Jul 23, 2021 |
| Agency Notice of Intent/Pre-proposal |
Aug 3, 2021 |
| Agency Proposal |
Sep 3, 2021
|
|
|
Institutional Research and Academic Career Development Awards (IRACDA) (K12) |
PAR-19-366 |
| |
National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of Jun 11, 2021 Has Passed — [All slots are filled]
|
Title
Institutional Research and Academic Career Development Awards (IRACDA) (K12)
Agencies
National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH)
Description
The Institutional Research and Academic Career Development Award (IRACDA) Program provides support for a mentored postdoctoral research experience at a research-intensive institution combined with an opportunity to develop critical teaching and mentoring skills at a teaching-intensive partner institution with a diverse student population. Accordingly, the IRACDA program requires effective partnerships between a research-intensive institution and a teaching-intensive partner institution that has a historical mission or a demonstrated commitment to educating students from groups underrepresented in the biomedical research workforce.
The primary goal of the IRACDA program is to develop a diverse pool of well-trained biomedical scientists who have the necessary knowledge and skills to pursue independent academic teaching and research careers. An additional goal of the IRACDA program is to benefit the teaching-intensive partner institutions, e.g., by providing research-oriented, early career teachers, mentors, and role models for the students; enhancing science educational offerings; providing research opportunities for the faculty and students; and/or bringing expertise with state-of-the-art research methods and technologies.
This Funding Opportunity Announcement (FOA) does not allow appointed scholars to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
More Information
https://grants.nih.gov/grants/guide/pa-files/PAR-19-366.html
Submission Limits
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.
Deadlines
| Internal Notice of Intent |
Jun 11, 2021 |
| Notification of Internal Competition |
Jun 12, 2021 |
| Internal Pre-proposal |
Jun 25, 2021 |
| Results of Internal Competition |
Jul 9, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Oct 1, 2021
|
|
|
Partnerships for Innovation (PFI) |
NSF 19-506 |
| |
National Science Foundation (NSF) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
| |
Notice of Intent Deadline of May 21, 2021 Has Passed — [All slots are filled]
|
Title
Partnerships for Innovation (PFI)
Agencies
National Science Foundation (NSF)
Description
The Partnerships for Innovation (PFI) Program within the Division of Industrial Innovation and Partnerships (IIP) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit. PFI has five broad goals, as set forth by the American Innovation and Competitiveness Act of 2017 (“the Actâ€, S.3084 — 114th Congress; Sec. 602. Translational Research Grants): (1) identifying and supporting NSF-sponsored research and technologies that have the potential for accelerated commercialization; (2) supporting prior or current NSF-sponsored investigators, institutions of higher education, and non-profit organizations that partner with an institution of higher education in undertaking proof-of-concept work, including the development of technology prototypes that are derived from NSF-sponsored research and have potential market value; (3) promoting sustainable partnerships between NSF-funded institutions, industry, and other organizations within academia and the private sector with the purpose of accelerating the transfer of technology; (4) developing multi-disciplinary innovation ecosystems which involve and are responsive to the specific needs of academia and industry; (5) providing professional development, mentoring, and advice in entrepreneurship, project management, and technology and business development to innovators. In addition, PFI responds to the mandate set by Congress in Section 601(c)(3) of the Act (Follow-on Grants), to support prototype or proof-of-concept development work by participants, including I-Corps participants, with innovations that because of the early stage of development are not eligible to participate in a Small Business Innovation Research Program or a Small Business Technology Transfer Program. Finally, PFI seeks to implement the mandate set by Congress in Section 102(c)(a) of the Act (Broader Impacts Review Criterion Update) by enhancing partnerships between academia and industry in the United States, and expanding the participation of women and individuals from underrepresented groups in innovation, technology translation, and entrepreneurship. This solicitation offers two broad tracks for proposals in pursuit of the aforementioned goals: The Technology Translation (PFI-TT) track offers the opportunity to translate prior NSF-funded research results in any field of science or engineering into technological innovations with promising commercial potential and societal impact. PFI-TT supports commercial potential demonstration projects for academic research outputs in any NSFfunded science and engineering discipline. This demonstration is achieved through proof-of-concept, prototyping, technology development and/or scale-up work. Concurrently, students and postdoctoral researchers who participate in PFI-TT projects receive education and leadership training in innovation and entrepreneurship. Successful PFI-TT projects generate technology-driven commercialization outcomes that address societal needs. The Research Partnerships (PFI-RP) track seeks to achieve the same goals as the PFI-TT track by supporting instead complex, multi-faceted technology development projects that are typically beyond the scope of a single researcher or institution and require a multi-organizational, interdisciplinary, synergistic collaboration. A PFI-RP project requires the creation of partnerships between academic researchers and third-party organizations such as industry, non-academic research organizations, federal laboratories, public or non-profit technology transfer organizations or other universities. Such partnerships are needed to conduct applied research on a stand-alone larger project toward commercialization and societal impact. In the absence of such synergistic partnership, the project’s likelihood for success would be minimal. The intended outcomes of both PFI-TT and PFI-RP tracks are: a) the commercialization of new intellectual property derived from NSF-funded research outputs; b) the creation of new or broader collaborations with industry (including increased corporate sponsored research); c) the licensing of NSF-funded research outputs to third party corporations or to start-up companies funded by a PFI team; and d) the training of future innovation and entrepreneurship leaders. WEBINARS: Webinars will be held to answer questions about the solicitation. Registration will be available on the NSF Partnerships for Innovation website (https://www.nsf.gov/PFI). Potential proposers and their partners are encouraged to attend.
More Information
https://www.nsf.gov/pubs/2019/nsf19506/nsf19506.pdf
Submission Limits
There is no limit on the number of PFI-TT proposals an organization may submit to a deadline of this solicitation. However, an organization may not submit more than one (1) new or resubmitted PFI-RP proposal to a deadline of this solicitation. This eligibility constraint will be strictly enforced. If an organization exceeds this limit, the first PFI-RP proposal received will be accepted, and the remainder will be returned without review. An organization may not receive more than two (2) awards from a submission deadline of this solicitation.
Deadlines
| Internal Notice of Intent |
May 21, 2021 |
| Notification of Internal Competition |
May 22, 2021 |
| Internal Pre-proposal |
Jun 7, 2021 |
| Results of Internal Competition |
Jun 18, 2021 |
| Agency Notice of Intent/Pre-proposal |
N/A |
| Agency Proposal |
Jul 14, 2021
|
|
Anyone wishing to submit a proposal for one of these programs should click on the appropriate link in the list above. To expedite the process of planning an internal competition, please submit your notice of intent as soon as you know you have an interest in the funding program. You are only required to include the name of the Principal Investigator, any co-PI's, and the subject or title of the proposed project. The deadline for the internal notice of intent is indicated above.
Office of the Vice President for Research
